Therapy of
oncologic diseases
After the diagnostic procedures are completed and a therapeutic strategy is developed, treatment begins. The integrative oncological approach includes a combination of complementary and conventional methods, often combining chemo therapy with oncothermia, radiation therapy with oncothermia, as well as biological and pharmaceutical medications.
Chemotherapy
In order to improve efficiency and reduce or completely avoid side effects, we apply IP Chemo-therapy (Insulin Potentiation Chemo-Therapy) whenever it is possible.
The core principle of IP Chemotherapy is to take advantage of cancer cells, increased sensitivity to insulin, making them more susceptible to Chemotherapy. Insulin increases the permeability of the cancer cells membrane, facilitating greater penetration of cytotoxic agents, which leads to increased drug effectiveness.
One of the main advantages of IP Chemotherapy is that it allows the application of a much lower dose of Chemotherapy compared to standard protocols, resulting in minimal side effects and enabling patients to maintain a good quality of life.
Oncothermia
Oncoтhermia is a therapeutic method used in the fight against cancer. It is most commonly applied in combination with Chemotherapy, Radiation therapy and other treatments, such as immunotherapy, dendritic cell therapy, etc.
Regardless of other treatment methods, oncothermia can be very useful as a method of stimulating the immune system, which greatly contributes to the fight against malignant diseases. Oncothermia is an established medical treatment in all EU countries, the USA and all medically developed countries.
Ionization radiation is not involved in oncothermia treatment, making it safe for patients, medical and support staff, as well as the environment.
In Europe, oncothermia treatments are scientifically recognized and approved by the European Society of Hyperthermic Oncology (ESHO).
Intravenous application
of biological substances
Vitamin C
The anti-cancer effects of Vitamin C have been known for at least four decades. Numerous studies have shown that Vitamin C, in sufficiently high concentrations, can effectively and selectively kill a large number of tumor cells.
Intravenous administration is more effective than oral administration, as it allows the body to reach the necessary concentration levels. High doses of Vitamin C administered intravenously have the following effects:
– Kill a large number of cancer cells
– Enhance the effectiveness of both Radiation-therapy and Chemo-therapy
– Protect normal tissues from the toxicity of Chemo-therapy, thereby reducing its complications
– Strengthen the immune system
– Improve the quality of life of cancer patients by reducing pain and increasing their energy and appetite.
Blood ozonation
Ozonization and Oxygenation are powerful methods for saturating the body with oxygen. This approach not only facilitates oxygenation, but also incorporates ozonation, effectively targeting cancer cells and other pathogens that may interfere, with the body's ability to fight cancer. Ozone has shown remarkable efficiency in neutralizing a wide range of pathogens, including viruses, bacteria, mold, yeast, fungi, cancer cells, and various toxins encountered in everyday life, such as toxic metals.
Ozone therapy can exhibit other interesting biological effects that can enhance the therapeutic effect:
1. Potential improvement in blood circulation and oxygen distribution, thereby increasing the effectiveness of chemotherapy and radiotherapy. Ozone therapy may also reduce their typical side effects.
2. Improvement of general metabolism.
3. Strengthening of the immune system.
Alkalization
For proper functioning, the human body requires a strictly controlled balance of acids and alkalines in the bloodstream. The normal pH of blood is between 7.35 and 7.45, which is slightly alkaline.
Many studies have shown that tumor cells can progress in an acidic environment. Specifically, scientists have discovered that cancer cells lacking sufficient oxygen become increasingly acidic, leading them to enter a dormant state. Cell dormancy can result in resistance to drugs and therapeutic procedures.
Alkalization helps reduce the acidity of the body, which leads to the awakening of cancer cells and their improved response to therapy.
IMMUNE STIMULATION THERAPY
Molecular therapies
Malignant diseases
Immune stimulation therapy works by increasing the body's natural defense against malignant diseases. This type of treatment stimulates our immune system to destroy cancer cells.
Dendritic Cell Cancer Therapy
The aim of dendritic cell therapy is to activate or strengthen the immune system. In immunotherapy, specific immune cells are used to target cancer cells. The therapy method uses so-called dendritic cells, which can recognize specific antigens on the surface of cancer cells. Thanks to improved tumor defense and a reduction in systemic side effects, the therapy is considered a promising treatment approach.
Clavic-Q-RE Cancer Therapy
Clavic-Q-RE is an adoptive cell therapy aiming to generate a robust anti-tumor immune response. Clavi-Q-RE contains different cell populations, isolated by the patient’s sample. They include monocytes, natural killer cells, as well as dendritic cells that are already activated in vivo against tumor antigens, which are expressed on cancer samples, cytotoxic T lymphocytes, and plasma cells that have been already differentiated in vivo against tumor antigens. Clavic-Q-RE is for autologous use only and is provided through the RGCC network.
Q-REstrain Therapy for Cancer
Q-REstrain consists of microRNA molecules with the ability to regulate the gene expression of a specific target. The short dsRNAs (double-stranded RNAs) are derived by cleavage of long dsRNA from Dicer and can be microRNAs (miRNAs). miRNAs then assemble with RNA-induced silencing complex (RISC) and cause gene silencing. RNAi has been used in the therapy of cancer. Targeting of specific proteins, through degradation of their mRNA, is very common in cancer treatment of different types of cancer.
Q-REstrain contains microRNAs isolated by the patient’s sample, leading to the degradation of specific mRNA molecules, which are overexpressed in this specific sample, thus regulating the expression. We can produce two kinds of Q-Restrain therapy RGCC 1 Aggressive and RGCC 1 Less Aggressive Therapy. Q-REstrain is for autologous use only and is provided through the RGCC network.
Vaccine Prep (ATA) Cancer Therapy
Vaccine Prep (ATA) is a new type of immunotherapy that activates or strengthens specific immune cells. The body's own cells are specifically designed to recognize and destroy cancer cells. We use the cellular fragments of dying tumor cells (CTC’s). These include organelles, mitochondria, cell membranes and cellular RNA and DNA. In our laboratory, we stimulate the development of dendritic cells and thus promote tumor antigen therapy.
Integrative oncology
Integrative oncology focused to the each patient individually, prepared evidence-based cancer treatments that carefully combines complementary with conventional cancer treatments. Integrative oncology aims to enable better quality of life, minimize side effects of treatment and improve treatment outcomes.
In most cases, patients response to one type of treatment is not enough effective, so it is necessary to use multiple forms of therapy. The use of combined therapeutic techniques has been recognized for its excellent results and minimal side effects. Each patient is unique in their disease. We consider every factor in the individual case, including the patient's age, genetic structure, type and location of cancer, disease progression, family history, current health and medical history.
Our target is to provide comprehensive and innovative treatment plans for each individual case and to offer patients a higher standard of care.
For our patients, cancer is not a verdict.
We firmly believe that, with an integrative approach to treatment, our patients can overcome even the most serious diagnosis and enjoy a good quality of life.
